Understanding the HE4 Blood Test: A Laboratory Medicine Specialist’s Guide to Interpretation Introduction Written by a Laboratory Medicine Specialist (MD.PhD.) When a pelvic mass is found on imaging, one of the most clinically urgent questions becomes: is it benign or malignant? The HE4 blood test — short for Human Epididymis Protein 4 — has emerged…
Understanding CA72-4: A Laboratory Specialist’s Guide to This Gastric Cancer Tumor Marker What this test measures, when it matters, and how to interpret it correctly — with clinical context you won’t find on the lab report. Laboratory Medicine Specialist, MD.PhD. CA72-4 (Cancer Antigen 72-4) is a high-molecular-weight mucin-type glycoprotein tumor marker most closely associated with…
❄️ Cold or Heat for Bruises? A Complete Guide From the Acute Phase to Recovery Bruises (contusions) are some of the most common minor injuries we experience in daily life—bumping into furniture, playing with kids, exercising, and more. Many people have heard the rule of thumb: “Cold first, then warm later.”Medically, this approach is correct….
HbA1c Testing & Hemoglobin Variants: A Laboratory Specialist’s Complete Guide to Accurate Interpretation Why your glycated hemoglobin result may be misleading — and what to do about it. Laboratory Medicine Specialist, MD.phD. HbA1c (glycated hemoglobin) is the gold-standard test for diagnosing and monitoring diabetes, reflecting average blood glucose over the past 2–3 months. However, genetic…
CYFRA 21-1 Tumor Marker: A Specialist’s Guide to Lung Cancer Diagnosis and Monitoring By a Laboratory Medicine Specialist, MD.phD. CYFRA 21-1 (Cytokeratin 19 Fragment) is a serum tumor marker with particular clinical value in non-small cell lung cancer (NSCLC), especially squamous cell carcinoma. This article — written by a board-certified Laboratory Medicine Specialist — explains…
Unintentional Weight Loss: A Critical Early Warning Sign Even When Cancer Has No Symptoms Many types of cancer progress silently in their early stages. They cause little to no pain, no obvious discomfort, and often no changes that patients can easily notice. This is why both patients and clinicians may miss the timing for early…
🧬 Why Most Cancers Have No Early Symptoms: A Clear Medical Explanation Many people assume that cancer should cause obvious signs early on—pain, bleeding, fatigue, or something noticeably abnormal.However, most cancers produce no symptoms in their early stages, which is why they often grow silently for years before being detected. This article explains why early-stage…
Clots in Blood Specimens: Why They Form and How They Compromise Your Lab Results By a Laboratory Medicine Specialist, MD.phD. Clot formation in blood specimens is a more common pre-analytical error than many clinicians realize. Even a microscopic partial clot can cause significant false decreases in WBC and platelet counts, spuriously prolonged PT/aPTT, and a…
Procalcitonin (PCT) Test: A Specialist’s Complete Guide to Sepsis Diagnosis and Antibiotic Stewardship By Laboratory Medicine Specialist, MD.phD. Quick summary: Procalcitonin (PCT) is a blood biomarker that rises sharply and specifically in bacterial infections and sepsis, while remaining low in viral illnesses — making it one of the most clinically valuable tools for guiding antibiotic decisions…
CRP (C-Reactive Protein) Test: A Specialist’s Guide to Understanding Inflammation Markers By Laboratory Medicine Specialist, MD.phD. Quick summary: The CRP (C-reactive protein) test is a blood test that measures a key marker of inflammation produced by the liver. It rises sharply within hours of infection, injury, or inflammatory disease — making it one of the most…
